IL17A and psoriasis: Suppression of NLRP3 inflammasome; reduction of pro-inflammatory cytokines (IL-1β, IL-6, IL-17, IL-18, IL-23); attenuation of inflammatory mediators (studied mainly in acne, psoriasis, hidradenitis suppurativa)